Human caspase 7 is positively controlled by SREBP-1 and SREBP-2.
暂无分享,去创建一个
Laure Gibot | Laurent Corcos | Brigitte Simon | B. Simon | L. Corcos | C. Le Jossic-Corcos | J. Metges | L. Gibot | Julie Follet | Jean-Philippe Metges | Pierrick Auvray | Catherine Le Jossic-Corcos | J. Follet | P. Auvray
[1] E. Alnemri,et al. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.
[2] H. Mo,et al. Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention , 2004, Experimental biology and medicine.
[3] C. Fielding,et al. Cholesterol and caveolae: structural and functional relationships. , 2000, Biochimica et biophysica acta.
[4] L. Corcos,et al. Caspase-2, a Novel Lipid Sensor under the Control of Sterol Regulatory Element Binding Protein 2 , 2005, Molecular and Cellular Biology.
[5] Keisuke Kuida,et al. Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis , 2006, Science.
[6] G. Fritz. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). , 2005, International journal of oncology.
[7] M. Seabra. Membrane association and targeting of prenylated Ras-like GTPases. , 1998, Cellular signalling.
[8] L. Corcos,et al. Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA , 2005, Cell Death and Differentiation.
[9] T. Narisawa,et al. Chemopreventive efficacy of low dose of pravastatin, an HMG-CoA reductase inhibitor, on 1,2-dimethylhydrazine-induced colon carcinogenesis in ICR mice. , 1996, The Tohoku journal of experimental medicine.
[10] M. Katz. Therapy Insight: potential of statins for cancer chemoprevention and therapy , 2005, Nature Clinical Practice Oncology.
[11] J.,et al. Human Acute Myeloid Leukemia Cells Bind to Bone Marrow Stroma Via a Combination of /3-1 and /3-2 Integrin Mechanisms , 2003 .
[12] L. Corcos,et al. Identification of a functional DNA binding site for the SREBP-1c transcription factor in the first intron of the human caspase-2 gene. , 2005, Biochimica et biophysica acta.
[13] Stephen B. Gruber,et al. Statins and cancer prevention , 2005, Nature Reviews Cancer.
[14] Keisuke Kuida,et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.
[15] Anindya Dutta,et al. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells , 2006, Molecular Cancer Therapeutics.
[16] C. Mantzoros,et al. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. , 2008, Atherosclerosis.
[17] Jay D. Horton,et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] Olivier Hermine,et al. Vital functions for lethal caspases , 2005, Oncogene.
[19] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[20] J. Goldstein,et al. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. , 2002, Molecular cell.
[21] M. Minden,et al. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells , 2001, Leukemia.
[22] M. Minden,et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis , 2002, Leukemia.
[23] N. Tsuji,et al. Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer* , 2007, Journal of Biological Chemistry.
[24] J. Mankovich,et al. Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.
[25] E. Sahai,et al. RHO–GTPases and cancer , 2002, Nature Reviews Cancer.
[26] R. Gibbs,et al. Detection of nonsterol isoprenoids by HPLC-MS/MS. , 2008, Analytical biochemistry.
[27] B. Kaina,et al. Rho GTPases: promising cellular targets for novel anticancer drugs. , 2006, Current cancer drug targets.
[28] Christopher Gerner,et al. Executioner caspase-3 and caspase-7 are functionally distinct proteases , 2008, Proceedings of the National Academy of Sciences.
[29] Y. Arai,et al. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. , 2001, Atherosclerosis.
[30] C. Laboisse,et al. Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. , 1982, Cancer research.
[31] Sung Goo Park,et al. Mining of caspase-7 substrates using a degradomic approach. , 2008, Molecules and cells.
[32] P. Auberger,et al. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation , 2006, Cell Death and Differentiation.
[33] Ju-yong Wang,et al. Downregulation of survivin expression and elevation of caspase-3 activity involved in pitavastatin-induced HepG 2 cell apoptosis. , 2007, Oncology reports.
[34] Roger J. Daly,et al. The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis , 2004, Journal of Mammary Gland Biology and Neoplasia.
[35] Jayoung Kim,et al. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.
[36] Á. Pascual,et al. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. , 2002, Atherosclerosis.
[37] D Tabor,et al. Regulation of gene expression by SREBP and SCAP. , 2000, Biochimica et biophysica acta.
[38] F. Dammacco,et al. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. , 2005, Carcinogenesis.